These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 9234001)

  • 1. Coronary heart disease in type 2 diabetic patients: common and different risk factors in men and women.
    Lunetta M; Barbagallo A; Attardo T; Crimi S; Sangiorgio L
    Diabetes Metab; 1997 Jun; 23(3):230-1. PubMed ID: 9234001
    [No Abstract]   [Full Text] [Related]  

  • 2. Diabetic nephropathy and risk factors for peripheral artery disease in Chinese with type 2 diabetes mellitus.
    Hsieh MC; Tien KJ; Perng DS; Hsiao JY; Chang SJ; Liang HT; Chen HC; Tu ST
    Metabolism; 2009 Apr; 58(4):504-9. PubMed ID: 19303971
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prolonged QTc interval and elevated heart rate identify the type 2 diabetic patient at high risk for cardiovascular death. The Bremen Diabetes Study.
    Linnemann B; Janka HU
    Exp Clin Endocrinol Diabetes; 2003 Jun; 111(4):215-22. PubMed ID: 12845560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Framingham risk equations underestimate coronary heart disease risk in diabetes.
    Stevens RJ; Coleman RL; Holman RR
    Diabet Med; 2005 Feb; 22(2):228. PubMed ID: 15660747
    [No Abstract]   [Full Text] [Related]  

  • 5. Joint effects of history of hypertension at baseline and type 2 diabetes at baseline and during follow-up on the risk of coronary heart disease.
    Hu G; Jousilahti P; Tuomilehto J
    Eur Heart J; 2007 Dec; 28(24):3059-66. PubMed ID: 17981826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence of coronary heart disease in type 2 diabetic men and women: impact of microvascular complications, treatment, and geographic location.
    Avogaro A; Giorda C; Maggini M; Mannucci E; Raschetti R; Lombardo F; Spila-Alegiani S; Turco S; Velussi M; Ferrannini E;
    Diabetes Care; 2007 May; 30(5):1241-7. PubMed ID: 17290034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasminogen activator inhibitor-1 activity in type 2 diabetes: a different relationship with coronary heart disease and diabetic retinopathy.
    Brazionis L; Rowley K; Jenkins A; Itsiopoulos C; O'Dea K
    Arterioscler Thromb Vasc Biol; 2008 Apr; 28(4):786-91. PubMed ID: 18239151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diabetes mellitus: a study utilizing the revised diagnostic criteria.
    de Andino RM; Mendoza M; Vera M; Martínez V
    Bol Asoc Med P R; 1988 Feb; 80(2):48-50. PubMed ID: 3348881
    [No Abstract]   [Full Text] [Related]  

  • 9. A longitudinal prospective study among Puerto Rican diabetic patients.
    Aguiló F; Allende MZ; Altieri PI
    Bol Asoc Med P R; 1985 Nov; 77(11):464-70. PubMed ID: 3867358
    [No Abstract]   [Full Text] [Related]  

  • 10. Hyperinsulinaemia as a possible risk factor of macrovascular disease in diabetes mellitus. An overview.
    Janka HU; Standl E
    Diabete Metab; 1987 Jul; 13(3 Pt 2):279-83. PubMed ID: 3308556
    [No Abstract]   [Full Text] [Related]  

  • 11. Prevalence of coronary risk factors in non-insulin dependent (type 2) diabetics.
    Walia M; Agarwal AK; Shah P; Yadav R; Singh CP; Yadav P
    J Assoc Physicians India; 1999 Nov; 47(11):1051-5. PubMed ID: 10862311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cardiac complications of type 2 diabetes].
    Lenaers M
    Rev Med Brux; 2000 Jun; 21(3):149-56. PubMed ID: 10925596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Risk factors of microangiopathy in patients with non-insulin dependent diabetes mellitus].
    Czech A; Szczeklik Z; Przybyś W
    Pol Tyg Lek; 1996 Jan; 51(1-5):35-6. PubMed ID: 8754299
    [No Abstract]   [Full Text] [Related]  

  • 14. Type 2 diabetes mellitus and risk of coronary heart disease: results of the 10-year follow-up of the PROCAM study.
    Buyken AE; von Eckardstein A; Schulte H; Cullen P; Assmann G
    Eur J Cardiovasc Prev Rehabil; 2007 Apr; 14(2):230-6. PubMed ID: 17446801
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of site and extent of clinically evident cardiovascular disease and atherosclerotic burden on new cardiovascular events in patients with Type 2 diabetes. The SMART study.
    Gorter PM; Visseren FL; Algra A; van der Graaf Y;
    Diabet Med; 2007 Dec; 24(12):1352-60. PubMed ID: 18042079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Ischemic heart disease and diabetes mellitus].
    Kmoch J; Panos J; Polácková H
    Vnitr Lek; 1977 May; 23(5):430-4. PubMed ID: 867876
    [No Abstract]   [Full Text] [Related]  

  • 17. Retinopathy predicts cardiovascular mortality in type 2 diabetic men and women.
    Juutilainen A; Lehto S; Rönnemaa T; Pyörälä K; Laakso M
    Diabetes Care; 2007 Feb; 30(2):292-9. PubMed ID: 17259497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Role of endothelin I and angiotensin II in type 2 diabetics with coronary disease].
    Mundo-Sagardía J; Altieri P; Banch H; González R; Escobales N; Crespo M; Rodríguez-Orengo J; Cardona F; Torrado J
    Bol Asoc Med P R; 2003; 95(5):45-50. PubMed ID: 15008361
    [No Abstract]   [Full Text] [Related]  

  • 19. [Diabetic complications in newly-diagnosed non-insulin-dependent diabetes].
    Uusitupa M; Siitonen O; Lehtinen J; Teräsvirta M; Pyörälä K
    Duodecim; 1986; 102(15):1024-34. PubMed ID: 3757840
    [No Abstract]   [Full Text] [Related]  

  • 20. Sex disparity in the management of dyslipidemia among patients with type 2 diabetes mellitus in a managed care organization.
    Nau DP; Mallya U
    Am J Manag Care; 2005 Feb; 11(2):69-73. PubMed ID: 15726854
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.